AI MARKET SCANNING

Corbus Pharmaceuticals Holding

📅 Next Catalyst: Nov 16, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +0.74%
MAX GAP RECORD +10.37%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $CRBP
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 16, 2026 Earnings Release 2026-11-16 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 06, 2026 Earnings Release 2026-08-06 (BEFORE OPEN)
-3.45%
May 12, 2026 Earnings Release 2026-05-12 (BEFORE OPEN)
+1.90%
Mar 09, 2026 Earnings Release 2026-03-09 (BEFORE OPEN)
+2.12%
Nov 12, 2025 Earnings Release 2025-11-12 (BEFORE OPEN)
-0.67%
Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN)
+1.71%
May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN)
-1.62%
Mar 11, 2025 Earnings Release 2025-03-11 (BEFORE OPEN)
+4.57%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.1%
Bullish Gaps (7)
Bearish Gaps (5)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $CRBP

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-08-10 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 3978m +4.06%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗